5‐ASA vs anti TNF‐ɑ
Clinical relapse · people with surgically‐induced remission in Crohn's disease
It is very uncertain whether 5‐ASAs changes clinical relapse compared with anti TNF‐ɑ (very low certainty).
1 finding from 1 review
- Oral 5‐aminosalicylic acid for maintenance of surgically‐induced remission in Crohn's disease 2019 · Cochrane Headline outcomes onlyRR 4 [1.01, 15.84]1 study · 34 participantsVery low